Peter Garred

23.0k total citations · 1 hit paper
416 papers, 17.2k citations indexed

About

Peter Garred is a scholar working on Immunology, Hematology and Molecular Biology. According to data from OpenAlex, Peter Garred has authored 416 papers receiving a total of 17.2k indexed citations (citations by other indexed papers that have themselves been cited), including 287 papers in Immunology, 81 papers in Hematology and 60 papers in Molecular Biology. Recurrent topics in Peter Garred's work include Complement system in diseases (212 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (41 papers) and Monoclonal and Polyclonal Antibodies Research (41 papers). Peter Garred is often cited by papers focused on Complement system in diseases (212 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (41 papers) and Monoclonal and Polyclonal Antibodies Research (41 papers). Peter Garred collaborates with scholars based in Denmark, Norway and United States. Peter Garred's co-authors include Hans O. Madsen, Arne Svejgaard, Lea Munthe‐Fog, Tina Hummelshøj, Claus Koch, Tom Eirik Mollnes, Mikkel‐Ole Skjoedt, Ying Jie, Steffen Thiel and Christian Honoré and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Peter Garred

400 papers receiving 16.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein

1995 649 citations Peter Garred, Steffen Thiel et al. The Journal of Immunology profile →

Peers

Countries citing papers authored by Peter Garred

Since Specialization

Citations

This map shows the geographic impact of Peter Garred's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Garred with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Garred more than expected).

Fields of papers citing papers by Peter Garred

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Garred. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Garred. The network helps show where Peter Garred may publish in the future.

Co-authorship network of co-authors of Peter Garred

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Garred. A scholar is included among the top collaborators of Peter Garred based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Garred. Peter Garred is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A novel complement-based drug candidate against fungal infections with promising results in a murine model of invasive pulmonary aspergillosis 2025 ·Immunobiology ·(unknown), Cornelia Speth, Günter Rambach, (unknown), (unknown), Reinhard Würzner, Peter Garred, Anne Rosbjerg	0
2	Isoform-specific detection and quantification of complement C4A via novel mAbs 2025 ·Immunobiology ·(unknown), (unknown), Karsten Skjoedt, Peter Garred	0
3	Distinct associations of the lectin pathway proteins MASP-2, MASP-3, and MAP-1 with clinical and serological profiles in Systemic Lupus Erythematosus 2025 ·Immunobiology ·(unknown), Elisabet Svenungsson, Iva Gunnarsson, (unknown), Peter Garred, Oskar Eriksson	0
4	Elevated Plasma MBL Levels Are Associated With Risk of Future Venous Thromboembolism: The HUNT Study 2025 ·Arteriosclerosis Thrombosis and Vascular Biology ·(unknown), (unknown), Omri Snir, Kristian Hindberg, Sigrid K. Brækkan, Steven P. Grover, Therese Haugdahl Nøst, Péter Gál, Gábor Pál, Christian Jonasson, Peter Garred, Tom Eirik Mollnes, Kristian Hveem, John‐Bjarne Hansen	0
5	Inhibition of Alternative and Terminal Complement Pathway Components Modulate the Immune Response Against Bacteria and Fungi in Whole Blood 2025 ·Scandinavian Journal of Immunology ·(unknown), (unknown), (unknown), Laura Pérez‐Alós, (unknown), Tom Eirik Mollnes, Peter Garred, Anne Rosbjerg	1
6	Unraveling the impact of SARS-CoV-2 mutations on immunity: insights from innate immune recognition to antibody and T cell responses 2024 ·Frontiers in Immunology ·Rafael Bayarri‐Olmos, (unknown), Anne Rosbjerg, (unknown), Charlotte Helgstrand, Per F. Nielsen, Laura Pérez‐Alós, (unknown), (unknown), Finn Matthiesen, Thomas Egebjerg, Cecilie Bo Hansen, Alessandro Sette, Alba Grifoni, Ricardo da Silva Antunes, Peter Garred	1
7	COVID‐19 Vaccination Before Initiating Rituximab Treatment Induces Strong Serological Response in Autoimmune Rheumatic Disease, Reducing Post‐Pandemic Concerns About the Impact of Rituximab 2024 ·ACR Open Rheumatology ·Christian Gytz Ammitzbøll, Marianne Kragh Thomsen, Lars Erik Bartels, Cecilie Bo Hansen, Marie‐Louise From Hermansen, (unknown), (unknown), (unknown), (unknown), (unknown), Susan Mikkelsen, (unknown), (unknown), (unknown), Christian Erikstrup, Peter Garred, Ellen‐Margrethe Hauge, Anne Troldborg	4
8	A novel selective leukocyte depletion human whole blood model reveals the specific roles of monocytes and granulocytes in the cytokine response to Escherichia coli 2023 ·Journal of Leukocyte Biology ·(unknown), Corinna Lau, (unknown), Camilla Schjalm, Dorte Christiansen, Peter Garred, Per H. Nilsson, Tom Eirik Mollnes	1
9	High anti-SARS-CoV-2 seroprevalence among unvaccinated mother–child pairs from a rural setting in north-eastern Tanzania during the second wave of COVID-19 2022 ·IJID Regions ·Omari Abdul Msemo, Laura Pérez‐Alós, Daniel T. R. Minja, Cecilie Bo Hansen, Samwel Gesase, George Mtove, (unknown), (unknown), (unknown), Louise Groth Grunnet, Dirk L. Christensen, Ib Christian Bygbjerg, David Burgner, Christentze Schmiegelow, Peter Garred, Line Hjort	0
10	Synthetic Oligodeoxynucleotide CpG Motifs Activate Human Complement through Their Backbone Structure and Induce Complement-Dependent Cytokine Release 2022 ·The Journal of Immunology ·Eline de Boer, Marina Sokolova, (unknown), (unknown), (unknown), Viktoriia Chaban, Jarle Vaage, (unknown), Trent M. Woodruff, Peter Garred, Per H. Nilsson, Tom Eirik Mollnes, Søren Erik Pischke	5
11	Influence of Glucose on Candida albicans and the Relevance of the Complement FH-Binding Molecule Hgt1 in a Murine Model of Candidiasis 2022 ·Antibiotics ·(unknown), (unknown), Günter Rambach, (unknown), (unknown), Christian X. Weichenberger, Peter Garred, Silke Huber, Cornelia Lass‐Flörl, Cornelia Speth, Reinhard Würzner	8
12	Prediction of Respiratory Failure and Mortality in COVID-19 Patients Using Long Pentraxin PTX3 2022 ·Journal of Innate Immunity ·Cecilie Bo Hansen, Håkon Sandholdt, (unknown), Laura Pérez‐Alós, Lise Pedersen, Simone Bastrup Israelsen, Peter Garred, Thomas Benfield	23
13	Anti-SARS-CoV-2 Seropositivity Among Medical Students in Copenhagen 2021 ·Open Forum Infectious Diseases ·(unknown), (unknown), Kamille Fogh, Cecilie Bo Hansen, Pernille Brok Nielsen, Theis Lange, Rasmus Bo Hasselbalch, Peter Garred, Kasper Iversen	7
14	Increase in the Complement Activation Product C4d and the Terminal Complement Complex sC5b-9 Is Associated with Disease Severity and a Fatal Outcome in Necrotizing Soft-Tissue Infection 2021 ·Journal of Innate Immunity ·Morten Hedetoft, Martin Bruun Madsen, Cecilie Bo Hansen, Ole Hyldegaard, Peter Garred	0
15	Therapeutic Targeting of the Complement System: From Rare Diseases to Pandemics 2021 ·Pharmacological Reviews ·Peter Garred, Andrea J. Tenner, Tom Eirik Mollnes	134
16	Shiga Toxin 2a Binds to Complement Components C3b and C5 and Upregulates Their Gene Expression in Human Cell Lines 2020 ·Toxins ·(unknown), Sneha Chatterjee, Rafael Bayarri‐Olmos, (unknown), Heribert Talasz, Wilfried Posch, (unknown), Peter Garred, Dorothea Orth‐Höller, (unknown), Reinhard Würzner	2
17	Targeting of Liver Mannan-Binding Lectin–Associated Serine Protease-3 with RNA Interference Ameliorates Disease in a Mouse Model of Rheumatoid Arthritis 2018 ·ImmunoHorizons ·Nirmal K. Banda, (unknown), Robert I. Scheinman, Rasmus Pihl, Hideharu Sekine, Teizo Fujita, Vibha Sharma, Annette G. Hansen, Peter Garred, Steffen Thiel, Anna Borodovsky, V. Michael Holers	15
18	The Lectin Complement Pathway in Patients with Necrotizing Soft Tissue Infection 2016 ·Journal of Innate Immunity ·Marco Bo Hansen, Lars S. Rasmussen, Katrine Pilely, (unknown), (unknown), Martin Bruun Madsen, Ole Hyldegaard, Peter Garred	13
19	Mouse mannose-binding lectin-A and ficolin-A inhibit lipopolysaccharide-mediated pro-inflammatory responses on mast cells 2013 ·BMB Reports ·Ying Jie, Hee Jung Kang, Ji Yeon Kim, Peter Garred, Myung‐Shik Lee, Yong Seok Lee	16
20	Design of a complement mannose-binding lectin pathway-specific activation system applicable at low serum dilutions 2006 ·Clinical & Experimental Immunology ·M Harboe, Peter Garred, (unknown), Gregory L. Stahl, A. Roos, Tom Eirik Mollnes	25

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact